KENNEY CHRISTOPHER JOHN bought XENE
January 9, 2026 · Form 4 insider transaction
KENNEY CHRISTOPHER JOHN bought 20,000 shares of Xenon Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderKENNEY CHRISTOPHER JOHN
RoleOfficer
SecurityRestricted Share Units
Transaction codeA: Grant or award
Transaction dateJanuary 9, 2026
Filing dateJanuary 9, 2026
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted share unit represents a contingent right to receive one Common Share vesting 25% on each of the first four anniversaries of the date of grant, beginning on January 9, 2027.